Bioengineering methods for tailoring treatment of Osteomyelitis: Advancing strategies and application
Materials Today Bio · 2025-12 · 35 · 102575
DOI: 10.1016/j.mtbio.2025.102575 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Materials Today Bio, 2025-12. Verfasst von Qi-Rui Geng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Province Science and Technology Support Program, Sichuan Provincial Administration of Traditional Chinese Medicine, National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteomyelitis (OM), an inflammatory disease of the bone due to pathogenic infection, represents one of the most significant challenges encountered by orthopedic surgeons worldwide. Under pathogenic, OM sites undergo persistent inflammation, oxidative stress, bone immune dysfunction, and abnormal osteocyte metabolism, resulting in recurrent bacterial infections and bone resorption. The curation of OM primarily relies on systematic high-dose antibiotics and local surgical debridement. Despite the discovery of various antimicrobial drugs in recent decades, there has been little clinical progress in OM eradication. The emergence of bioengineering materials offers great hope for addressing this issue. Beyond the antimicrobial activity, they often possess one or more of the following functions: antioxidant, anti-inflammatory, immunomodulatory, angiogenic and osteogenic. These materials have shown promising therapeutic effects in animal OM models. However, extensive and comprehensive animal studies and clinical trials are still needed to determine their direct and lasting impact on OM patients. This review integrates the complex microenvironmental characteristics of OM, delving into the construction principles and mechanisms of various bioengineering methods. It aims to enhance understanding of their suitability in meeting the therapeutic needs of OM. Additionally, it explores the clinical applicability and future prospects of multifunctional biomaterials in treating OM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
- National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan, 610065, China.
- Med-X Center for Manufacturing, Sichuan University, Chengdu, Sichuan, 610041, China.
Förderung
- Sichuan Province Science and Technology Support Program
- Sichuan Provincial Administration of Traditional Chinese Medicine
- National Natural Science Foundation of China
Zitieren
APA
Geng, Q. R., Li, Y. X., Gong, H., Gan, T. J., Yin, S. J., Ma, X. K., Zheng, C., Wu, Y., Zhang, H., & Wang, Y. (2025). Bioengineering methods for tailoring treatment of Osteomyelitis: Advancing strategies and application. Materials Today Bio, 35, 102575. https://doi.org/10.1016/j.mtbio.2025.102575
Vancouver
Geng QR, Li YX, Gong H, Gan TJ, Yin SJ, Ma XK, et al. Bioengineering methods for tailoring treatment of Osteomyelitis: Advancing strategies and application. Materials Today Bio. 2025;35:102575. doi:10.1016/j.mtbio.2025.102575
BibTeX
@article{Geng2025,
author = {Geng, Qi-Rui and Li, Ya-Xing and Gong, Heng and Gan, Ting-Jiang and Yin, Shi-Jiu and Ma, Xi-Kun and Zheng, Cheng and Wu, Ye and Zhang, Hui and Wang, Yunbing},
title = {Bioengineering methods for tailoring treatment of Osteomyelitis: Advancing strategies and application},
journal = {Materials Today Bio},
year = {2025},
volume = {35},
pages = {102575},
doi = {10.1016/j.mtbio.2025.102575}
}
EUVIMED